Close

UPDATE: MannKind (MNKD) Says Advancing Inhaled EpiPen Rival, May Seek Partner

Go back to UPDATE: MannKind (MNKD) Says Advancing Inhaled EpiPen Rival, May Seek Partner
Mannkind Corporation (NASDAQ: MNKD) Delayed: 4.18 --0 (-0%)
Previous Close $4.18    52 Week High $2.51 
Open $4.18    52 Week Low $0.41 
Day High $4.18    P/E N/A 
Day Low $4.18    EPS $-0.64 
Volume 52,624